Bixiye
P66-17 Clarification of Mid-Level Definitions
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Natiijooyinka Raadinta
Soo bandhiga 3051 - 3060 ee natiijooyinka 4130
Bixiye
P51R1-17 Updated: Accountable Care Organization Product and Network Name Changes
Taariikhda uu dhaqangalayo Barnaamijka: Nov 15, 2017
Bixiye
P60-17 2018 Renewal Changes Summary for Institutional Providers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2017
Bixiye
P61-16 New Drug-Related Prior Authorization Criteria for Amitiza and Linzess
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2016
Bixiye
P52-16 DHS Guidelines for Mental Health-Targeted Case Management Services for MHCP Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 04, 2016
Bixiye
P63-17 New Drug-Related PA with Quantity Limit Criteria: Otezla (apremilast)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Bixiye
P63-16 Drug Related Prior Authorization Criteria Changes for Ampyra, H.P. Acthar Gel, Transmucosal Fentanyl, Growth Hormone, and Oral Pulmonary Arterial Hypertension Agents
Taariikhda uu dhaqangalayo Barnaamijka: Des 20, 2016
Bixiye
P31-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Thrombopoietin Receptor Agents
Taariikhda wax ku ool ah ee barnaamijka: Jun 05, 2017
Bixiye
P57-17 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo barnaamijka: Okt 24, 2017
Bixiye
P39-17 Concurrent Review for Inpatient Hospital Services at Select Facilities
Taariikhda dhaqangalka Barnaamijka: Jul 11, 2017